Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-25Clinical Trial Update: Special Drug Use Investigation for LAMICTAL Bipolar
A Special Drug Use Investigation for Lamictal (lamotrigine) in bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Zonisamide for Heavy Drinkers With Bipolar Disorder [Phase 2]
A Phase 2 trial evaluating zonisamide for heavy drinking in individuals with bipolar disorder was terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-04-21Clinical Trial Update: Lamotrigine in the Treatment of Bipolar Disorder in Women of Reproductive Age
Clinical trial on Lamotrigine for bipolar disorder in women of reproductive age has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: Using Mental Health Telemetry to Predict Relapse and Re-hospitalization in Mood Disorders [NA]
A clinical trial evaluating the use of mental health telemetry to predict relapse and re-hospitalization in mood disorders has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Sensoril(Ashwaganhda)for Bipolar Disorder [Phase 3]
Phase 3 trial of Sensoril (ashwagandha extract) for bipolar disorder has completed; results were posted in 2016.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: Low Field Magnetic Stimulation (LFMS) in Mood Disorders: 6 Treatments [Phase 1]
Phase 1 trial of Low Field Magnetic Stimulation (LFMS) for mood disorders has been suspended.
-
CLINICAL_TRIALS trial_result · 2016-04-07Clinical Trial Update: Observation Study of the Clinical Management of Bipolar Disorder
This is an observational study by AstraZeneca on the clinical management of bipolar disorder that has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-05Clinical Trial Update: Correlation Between Sagittal Balance of the Spine and Psychopathological Profile
A terminated clinical trial from University Hospital Strasbourg investigated whether sagittal spine alignment correlates with psychopatholog…
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Quetiapine in Patients With Bipolar and Alcohol Abuse/Dependence [Phase 4]
A Phase 4 trial evaluating quetiapine for patients with bipolar disorder and alcohol abuse/dependence has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia [Phase 4]
Phase 4 clinical trial evaluating omega-3 fatty acids (Lovaza) for hypertriglyceridemia associated with second-generation antipsychotics. Re…
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: Study Using Pregnenolone to Treat Bipolar Depression [Phase 4]
A Phase 4 clinical trial evaluating pregnenolone for the treatment of bipolar depression has completed with results posted.
-
CLINICAL_TRIALS research · 2016-03-30Clinical Trial Update: The MONARCA Project (MONitoring, treAtment and pRediCtion of bipolAr Disorder Episodes) [NA]
The MONARCA Project investigates monitoring and prediction of bipolar disorder episodes, including treatment considerations. The study statu…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder [Phase 3]
Phase 3 safety and efficacy study of ramelteon (TAK-375) for sublingual administration in adults with Bipolar I disorder was terminated; res…
-
FDA approval · 2016-03-08FDA Approved: QUETIAPINE FUMARATE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved Quetiapine Fumarate as a generic tablet under Original Application (ANDA 202674) for Unichem Pharmaceuticals (USA), Inc.
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Omega-3 and Therapy Study for Childhood Bipolar Disorder- Not Otherwise Specified [Phase 1]
Phase 1 trial evaluating omega-3 fatty acids in combination with therapy for childhood bipolar disorder has completed.
-
FDA approval · 2016-03-01FDA Approved: RISPERIDONE — Supplemental Application (Janssen Pharmaceutical, Inc.)
FDA approved a supplemental application for risperidone submitted by Janssen Pharmaceutical, Inc.
-
FDA approval · 2016-03-01FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Risperdal M-Tab (risperidone) from Janssen Pharmaceuticals.
-
FDA approval · 2016-03-01FDA Approved: RISPERDAL — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Risperdal (risperidone) by Janssen Pharmaceuticals, Inc.
-
FDA approval · 2016-02-26FDA Approved: LITHIUM CARBONATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Lithium Carbonate submitted by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2016-02-18FDA Approved: DEPAKOTE ER — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Depakote ER (divalproex sodium) from AbbVie Inc., granting an additional regulatory authorizatio…
-
FDA label_change · 2016-02-18FDA Approved: DEPAKOTE SPRINKLES — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Depakote Sprinkles (divalproex sodium) from AbbVie, resulting in a labeling update for the produ…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Study of Aripiprazole to Reduce Medical Risks in Bipolar Disorder [NA]
Terminated study evaluating aripiprazole to reduce medical risks in bipolar disorder with metabolic syndrome; results were posted on Februar…
-
CLINICAL_TRIALS research · 2016-02-09Clinical Trial Update: Remote Monitoring and Support for Patients With Schizophrenia, Schizoaffective or Bipolar Disorder on Adherence [NA]
Clinical trial update examining remote monitoring and support to improve medication adherence in patients with schizophrenia, schizoaffectiv…
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Risperdal Consta for Bipolar Disorder [Phase 3]
A Phase 3 trial evaluating Risperdal Consta for Bipolar I Disorder has completed, and the trial results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features. [Phase 3]
A Phase 3 trial evaluating the safety and tolerability of aripiprazole in adolescents with schizophrenia and in children/adolescents with Bi…